ArticleTherapeutic advances in medical oncology2020

Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.

Atsushi Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.